Indirect and direct inhibition of dopamine beta-hydroxylase by amphetamine in storage vesicles and synaptosomes
- PMID: 779909
- PMCID: PMC1667116
- DOI: 10.1111/j.1476-5381.1976.tb07471.x
Indirect and direct inhibition of dopamine beta-hydroxylase by amphetamine in storage vesicles and synaptosomes
Abstract
1 To elucidate the mechanism by which amphetamine produces a functional inhibition of dopamine beta-hydroxylase (DBH), the actions of amphetamine on amine uptake and beta-hydroxylation were examined in isolated adrenal storage vesicles and in whole brain synaptosomes of the rat. 2 Amphetamine produces a competitive inhibition of catecholamine incorporation into adrenal vesicles with a Ki of 279 muM; this action of the drug accounted for slightly less than half of the total inhibition of beta-hydroxylation in the vesicles, indicating that the interference by amphetamine of access of substrate to the enzyme compartment plays an important role in functional inhibition of DBH. The remainder of the effect in vesicles probably represents direct inhibition of the enzyme. 3 In synaptosomes, similar actions on uptake of substrate and on functional enzyme activity were noted, indicating that amphetamine-induced inhibition of the neuronal amine pump can also affect DBH activity if the substrate is supplied exogenously. 4 In addition to the effects of amphetamine in vitro, chronic administration of amphetamine to rats produced an increase in total activity of adrenal DBH. 5 The net effect of amphetamine on DBH activity thus represents the summation of direct inhibition of the enzyme, indirect inhibition via reduced access of substrate and enhancement of activity via trans-synaptic induction.
Similar articles
-
Effects of in vivo amphetamine administration on dopamine synthesis regulation in rat brain striatal synaptosomes.J Pharmacol Exp Ther. 1981 Jun;217(3):686-91. J Pharmacol Exp Ther. 1981. PMID: 7229999
-
Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-β-hydroxylase: comparison with nepicastat.Eur J Pharmacol. 2015 Mar 15;751:50-8. doi: 10.1016/j.ejphar.2015.01.034. Epub 2015 Jan 29. Eur J Pharmacol. 2015. PMID: 25641750
-
Inhibition of dopamine beta-hydroxylase by 4-hydroxypyrazole: ethanol-pyrazole effects on serum dopamine beta-hydroxylase in vivo.J Pharmacol Exp Ther. 1978 Jul;206(1):69-74. J Pharmacol Exp Ther. 1978. PMID: 660559
-
Dopamine beta-hydroxylase in health and disease.Crit Rev Clin Lab Sci. 1980;12(3):241-77. doi: 10.3109/10408368009108731. Crit Rev Clin Lab Sci. 1980. PMID: 6998654 Review.
-
Dopamine-beta-hydroxylase inhibition: a novel sympatho-modulatory approach for the treatment of congestive heart failure.Curr Pharm Des. 1998 Dec;4(6):469-79. Curr Pharm Des. 1998. PMID: 10197057 Review.
Cited by
-
Demonstration of reduced levels of zinc in rat brain after treatment with d-amphetamine, but not after treatment with reserpine.Histochemistry. 1985;83(2):181-7. doi: 10.1007/BF00495151. Histochemistry. 1985. PMID: 4044304
-
Morphometric and neurosecretory changes in supraoptic neurons after D-amphetamine treatment.J Neural Transm Gen Sect. 1992;89(1-2):81-92. doi: 10.1007/BF01245354. J Neural Transm Gen Sect. 1992. PMID: 1418869
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous